Valsartan
Drug · tier A · 8 trials (1 recruiting) · 13 publications · score 80.0
Indapamide
Drug · tier A · 8 trials (1 recruiting) · 13 publications · score 79.5
Lisinopril
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 79.5
Amlodipine Besylate
Drug · tier A · 8 trials (0 recruiting) · 10 publications · score 79.0
Chlorthalidone
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 79.0
Nifedipine
Drug · tier A · 8 trials (1 recruiting) · 13 publications · score 79.0
Candesartan Cilexetil
Drug · tier A · 8 trials (1 recruiting) · 11 publications · score 78.5
Metoprolol
Drug · tier A · 7 trials (0 recruiting) · 14 publications · score 74.0
Eplerenone
Drug · tier A · 8 trials (0 recruiting) · 12 publications · score 73.5
Irbesartan
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 72.0
Losartan Potassium
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 64.0
Captopril
Drug · tier A · 4 trials (0 recruiting) · 15 publications · score 58.5
Bisoprolol Fumarate
Drug · tier A · 8 trials (1 recruiting) · 4 publications · score 58.0
Enalapril Maleate
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 56.5
Metoprolol Succinate
Drug · tier A · 7 trials (0 recruiting) · 5 publications · score 54.0
Perindopril Arginine
Drug · tier A · 2 trials (0 recruiting) · 7 publications · score 45.0
Moxonidine
Drug · tier A · 1 trials (0 recruiting) · 7 publications · score 44.5
Coenzyme Q10
Supplement · tier C · 0 trials (0 recruiting) · 14 publications · score 35.0
Rauwolfia Serpentina
Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 32.0
Berberine
Supplement · tier C · 0 trials (0 recruiting) · 6 publications · score 26.0
Garlic (Allium sativum)
Supplement · tier C · 1 trials (1 recruiting) · 3 publications · score 20.0
Hawthorn (Crataegus)
Supplement · tier C · 1 trials (0 recruiting) · 1 publications · score 10.5
Research map, not treatment advice. Built 2026-10-07.